stride trial semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 Effect of GLP-1 agonists Strength:7.2mg Appetite & Fat Metabolism

stride trial semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 Effect of GLP-1 agonists Strength:7.2mg Appetite & Fat Metabolism

Effect of GLP-1 agonists on testosterone levels: a systematic review and meta-analysis - PMC

The combination made sense for my goals and I would consider running it again after a proper break

Appetite & Fat Metabolism

Strength:7.2mg

If 20 million people eventually are being treated with a GLP-1, and experience less appetite for sweets, that adds up to billions in lost revenue for that sector